Redcare Pharmacy stock: Q3 profit grows as German Rx leads

Redcare Pharmacy reported a stronger third quarter on Thursday, October 29, 2026, with prescription medicines again driving growth and profitability. The figures were published in an EQS News release carried by Deutsche Boerse.

Rx growth lifts quarterly profitability

Group revenue increased 18 percent year over year to EUR 847 million. Prescription revenue rose 31 percent to EUR 358 million, including 56 percent growth in Germany to EUR 197 million. Non-prescription revenue increased 9 percent to EUR 489 million, while the active customer base reached 15.2 million at the end of September.

Adjusted EBITDA rose 68 percent to EUR 28.7 million, lifting the margin to 3.4 percent from 2.4 percent. Net income reached EUR 1 million, marking a second consecutive quarterly profit. Free cash flow was EUR 15 million in the quarter.

Outlook holds despite softer October

Redcare confirmed its upgraded 2026 targets: total revenue growth of 16 to 18 percent, non-prescription growth of 10 to 12 percent, German prescription revenue of EUR 730 million to EUR 760 million and an adjusted EBITDA margin of 2.5 to 3.0 percent. Management said October non-prescription growth was running below 10 percent as cough-and-cold sales started slowly.

DACH adjusted EBITDA reached EUR 29 million, with the regional margin rising to 4.2 percent from 3.0 percent. International adjusted EBITDA remained negative at EUR 1 million, leaving execution and operating leverage central to the investment case.

Redcare Pharmacy stock traded at 69.45 euros on Lang & Schwarz at 16:44 CET on Friday, October 30, 2026, 6.53 percent below the Xetra close of Thursday, October 29. The latest own report had cited 71.18 euros at 10:35 CET; the later quote was 2.43 percent lower. Investors can follow the real-time quote of Redcare Pharmacy stock.

Broader Dutch equities can be followed through the AEX index.

More news and analyses on Redcare Pharmacy stock will follow the fiscal 2026 trading update scheduled for January 11, 2027.